加强大麻研究方法:研讨会报告。

IF 4.3 Q1 PHARMACOLOGY & PHARMACY
Jonathan M Samet, Jessica Barrington-Trimis, Lisa Bero, Ashley Brooks-Russell, Meghan Buran, Julia Dilley, Darin Erickson, Marilyn Huestis, Kent Hutchison, Thomas L Jeanne, Michael Kosnett, David J Kroll, Stephen Lankenau, Richard Miech, Rosalie Liccardo Pacula, Paula Riggs, Neeloofar Soleimanpour, Steven Teutsch, Gregory Tung, George Sam Wang
{"title":"加强大麻研究方法:研讨会报告。","authors":"Jonathan M Samet, Jessica Barrington-Trimis, Lisa Bero, Ashley Brooks-Russell, Meghan Buran, Julia Dilley, Darin Erickson, Marilyn Huestis, Kent Hutchison, Thomas L Jeanne, Michael Kosnett, David J Kroll, Stephen Lankenau, Richard Miech, Rosalie Liccardo Pacula, Paula Riggs, Neeloofar Soleimanpour, Steven Teutsch, Gregory Tung, George Sam Wang","doi":"10.1186/s42238-025-00314-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Progressive legalization of medical and recreational cannabis markets at the state-level has led to rapid growth of medical and recreational cannabis markets and to product diversification with emerging products having high concentrations of delta-9-tetrahydrocannabinol. Research on these products is still limited and the evidence available for policy formulation is diminished by methodological limitations.</p><p><strong>Methods: </strong>As a step towards addressing these limitations, the Colorado School of Public Health convened a multidisciplinary workshop that addressed four areas of cannabis research: epidemiological, clinical, surveillance, and policy. Workshop participants provided recommendations in each area to advance research on cannabis to make it more informative for decision-making on key policy topics. Emphasis was placed on assessment of use of cannabis products by study participants.</p><p><strong>Results: </strong>Recommendations for research methods and their implementation were made in the four areas. Those for epidemiology include using a core set of exposure assessment measures across three domains; developing this core set through a national and/or international scientific consensus process; ensuring the core set of measures are validated and readily available; and updating the core set periodically to account for ongoing changes in the cannabis landscape. Recommendations in the clinical research area include standard dosing and dosing terminology; standardized data collection instruments; identifying biomarkers for detecting cannabis exposure; and biological matrices. Policy research recommendations were offered for state regulators, evaluators/researchers, and policy makers. Surveillance recommendations include developing and implementing a novel and nimble surveillance system to monitor use of high-concentration forms of cannabis; adding questions to existing surveillance systems with the objective of monitoring high-concentration cannabis and adverse outcomes; and elevating the coordination, synthesis, and dissemination of findings in existing data sources that could signal adverse outcomes from high-concentration cannabis.</p><p><strong>Conclusions: </strong>Given the changing marketplace, it is urgent to improve the informativeness of cannabis research through enhanced research methods.</p>","PeriodicalId":101310,"journal":{"name":"Journal of cannabis research","volume":"7 1","pages":"69"},"PeriodicalIF":4.3000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12482547/pdf/","citationCount":"0","resultStr":"{\"title\":\"Enhancing Methods for Research on Cannabis: A Workshop Report.\",\"authors\":\"Jonathan M Samet, Jessica Barrington-Trimis, Lisa Bero, Ashley Brooks-Russell, Meghan Buran, Julia Dilley, Darin Erickson, Marilyn Huestis, Kent Hutchison, Thomas L Jeanne, Michael Kosnett, David J Kroll, Stephen Lankenau, Richard Miech, Rosalie Liccardo Pacula, Paula Riggs, Neeloofar Soleimanpour, Steven Teutsch, Gregory Tung, George Sam Wang\",\"doi\":\"10.1186/s42238-025-00314-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>Progressive legalization of medical and recreational cannabis markets at the state-level has led to rapid growth of medical and recreational cannabis markets and to product diversification with emerging products having high concentrations of delta-9-tetrahydrocannabinol. Research on these products is still limited and the evidence available for policy formulation is diminished by methodological limitations.</p><p><strong>Methods: </strong>As a step towards addressing these limitations, the Colorado School of Public Health convened a multidisciplinary workshop that addressed four areas of cannabis research: epidemiological, clinical, surveillance, and policy. Workshop participants provided recommendations in each area to advance research on cannabis to make it more informative for decision-making on key policy topics. Emphasis was placed on assessment of use of cannabis products by study participants.</p><p><strong>Results: </strong>Recommendations for research methods and their implementation were made in the four areas. Those for epidemiology include using a core set of exposure assessment measures across three domains; developing this core set through a national and/or international scientific consensus process; ensuring the core set of measures are validated and readily available; and updating the core set periodically to account for ongoing changes in the cannabis landscape. Recommendations in the clinical research area include standard dosing and dosing terminology; standardized data collection instruments; identifying biomarkers for detecting cannabis exposure; and biological matrices. Policy research recommendations were offered for state regulators, evaluators/researchers, and policy makers. Surveillance recommendations include developing and implementing a novel and nimble surveillance system to monitor use of high-concentration forms of cannabis; adding questions to existing surveillance systems with the objective of monitoring high-concentration cannabis and adverse outcomes; and elevating the coordination, synthesis, and dissemination of findings in existing data sources that could signal adverse outcomes from high-concentration cannabis.</p><p><strong>Conclusions: </strong>Given the changing marketplace, it is urgent to improve the informativeness of cannabis research through enhanced research methods.</p>\",\"PeriodicalId\":101310,\"journal\":{\"name\":\"Journal of cannabis research\",\"volume\":\"7 1\",\"pages\":\"69\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12482547/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of cannabis research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s42238-025-00314-7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cannabis research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42238-025-00314-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

目标:国家一级医疗和娱乐大麻市场的逐步合法化导致医疗和娱乐大麻市场迅速增长,并导致产品多样化,新兴产品含有高浓度的-9-四氢大麻酚。对这些产品的研究仍然有限,可用于制定政策的证据因方法的限制而减少。方法:作为解决这些限制的一个步骤,科罗拉多公共卫生学院召开了一次多学科讲习班,讨论大麻研究的四个领域:流行病学、临床、监测和政策。讲习班与会者在每个领域提出了建议,以推进大麻研究,使其为关键政策议题的决策提供更多信息。重点放在研究参与者对大麻产品使用情况的评估上。结果:对四个领域的研究方法及其实施提出了建议。流行病学方面的措施包括在三个领域使用一套核心暴露评估措施;通过国家和/或国际科学共识进程制定这一核心集;确保核心措施得到验证并随时可用;并定期更新核心集,以说明大麻景观的持续变化。临床研究领域的建议包括标准给药和给药术语;标准化数据收集工具;确定用于检测大麻暴露的生物标志物;还有生物基质。政策研究建议提供给国家监管机构,评估/研究人员和政策制定者。监测建议包括制定和实施一种新颖而灵活的监测系统,以监测高浓度大麻的使用情况;对现有监测系统提出问题,目的是监测高浓度大麻及其不良后果;加强协调、综合和传播现有数据来源中的发现,这些发现可能表明高浓度大麻的不良后果。结论:鉴于不断变化的市场,迫切需要通过加强研究方法来提高大麻研究的信息量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Enhancing Methods for Research on Cannabis: A Workshop Report.

Enhancing Methods for Research on Cannabis: A Workshop Report.

Enhancing Methods for Research on Cannabis: A Workshop Report.

Aims: Progressive legalization of medical and recreational cannabis markets at the state-level has led to rapid growth of medical and recreational cannabis markets and to product diversification with emerging products having high concentrations of delta-9-tetrahydrocannabinol. Research on these products is still limited and the evidence available for policy formulation is diminished by methodological limitations.

Methods: As a step towards addressing these limitations, the Colorado School of Public Health convened a multidisciplinary workshop that addressed four areas of cannabis research: epidemiological, clinical, surveillance, and policy. Workshop participants provided recommendations in each area to advance research on cannabis to make it more informative for decision-making on key policy topics. Emphasis was placed on assessment of use of cannabis products by study participants.

Results: Recommendations for research methods and their implementation were made in the four areas. Those for epidemiology include using a core set of exposure assessment measures across three domains; developing this core set through a national and/or international scientific consensus process; ensuring the core set of measures are validated and readily available; and updating the core set periodically to account for ongoing changes in the cannabis landscape. Recommendations in the clinical research area include standard dosing and dosing terminology; standardized data collection instruments; identifying biomarkers for detecting cannabis exposure; and biological matrices. Policy research recommendations were offered for state regulators, evaluators/researchers, and policy makers. Surveillance recommendations include developing and implementing a novel and nimble surveillance system to monitor use of high-concentration forms of cannabis; adding questions to existing surveillance systems with the objective of monitoring high-concentration cannabis and adverse outcomes; and elevating the coordination, synthesis, and dissemination of findings in existing data sources that could signal adverse outcomes from high-concentration cannabis.

Conclusions: Given the changing marketplace, it is urgent to improve the informativeness of cannabis research through enhanced research methods.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信